Medical Devices · AI 추천
Which robotic surgery systems do AI platforms recommend when hospitals compare surgical robotics programs? · 2026년 6월 6일 기준 데이터
조회된 플랫폼
추천된 브랜드
15
AI 언급 횟수
263
AI 검색량
46.8K
ChatGPT, Claude, Gemini, Perplexity의 실제 AI 응답에서 추출한 브랜드입니다.
“best surgical robots”라는 질문을 받았을 때, AI 플랫폼은 15개 브랜드를 추천했습니다. Stryker(이)가 가장 자주 언급되었으며, 4개 플랫폼에 걸쳐 7회 등장했습니다. 기타 주요 추천 브랜드로는 Medtronic, Intuitive Surgical, CMR Surgical(이)가 있습니다.
Stryker
stryker.com
Medtronic
medtronic.com
Intuitive Surgical
intuitive.com
CMR Surgical
cmrsurgical.com
Zimmer Biomet
zimmerbiomet.com
Medical Microinstruments
mmimicro.com
Mako System
stryker.com
Hugo RAS System
medtronic.com
ROSA
zimmerbiomet.com
Symani Surgical System
mmimicro.com
Versius Plus
cmrsurgical.com
Kai
koutechmedical.com
Johnson & Johnson
jnj.com
Asensus
asensus.com
LEM Surgical
lemsurgical.com
“best surgical robots” 질문을 받았을 때 4개 AI 플랫폼의 실제 응답
각 플랫폼은 고유한 시각을 제공합니다. ChatGPT(o4-mini-2025-04-16)는 9개의 출처(을)를 인용한 상세한 응답을 제공했습니다. Claude(claude-sonnet-4-6)는 19개의 출처(을)를 인용한 상세한 응답을 제공했습니다. Gemini(gemini-2.5-flash)는 10개의 출처(을)를 인용한 상세한 응답을 제공했습니다. Perplexity(sonar)는 10개의 출처(을)를 인용한 간결한 응답을 제공했습니다.
o4-mini-2025-04-16
Below is an in-depth overview of the leading surgical-robot systems in 2026. Each platform is evaluated on its clinical breadth (number and type of cleared procedures), technical capabilities (arm architecture, imaging/AI integration, force feedback), economic considerations (system cost, per-procedure disposables), and real-world adoption (installed base, market share).
• Overview: Fifth-generation soft-tissue robot from Intuitive Surgical, the long-time market leader.
• Clinical reach: 60 + U.S.- and EU-cleared procedures across general surgery, urology, gynecology, thoracic, colorectal, head & neck.
• Key features:
– Advanced EndoWrist instruments with 7-degrees-of-freedom and wristed motion.
– 3D high-definition TrueVision imaging with 10 000× digital zoom.
– Integrated AI tissue-analytics for real-time margin assessment.
– Haptic-style “force visualization” to alert—though not fully resist—excessive instrument loads.
• Economics: System list $1.5–2.5 M; instruments/instruments $2 000–3 500 per case.
• Adoption: ~9 000 units installed globally in 2026, >70 % soft-tissue RAS market share, >9 M procedures performed since launch (robotomated.com).
• Overview: Market-dominant orthopedic-specific robot for hip/knee replacement.
• Clinical reach: CT-based planning and execution for total knee arthroplasty (TKA), partial knee, total hip.
• Key features:
– Rigid haptic boundaries (“AccuStop”) that physically halt the saw/burr at pre-planned margins.
– Automatic intraoperative limb-alignment analytics.
– Fully integrated with Stryker’s Triathlon™ implants and digital pre-op planning suite.
• Economics: System $1.0–1.5 M; disposable guidance arrays $500 per case.
• Adoption: ~85 % share of U.S. robotic ortho market, >1 500 sites (robotomated.com).
• Overview: Modular, open-platform competitor to da Vinci, with flexible OR footprint.
• Clinical reach: Cleared for urology, general surgery, gynecology; thoracic and colorectal submissions pending.
• Key features:
– Four independent robotic arms on mobile carts for customizable positioning.
– Open instrument ecosystem allows third-party tools.
– “Hugo Digital Cockpit” for integrated OR monitoring and potential multi-console training.
• Economics: List $0.8–1.5 M; instruments $1 000–2 000/case.
• Adoption: Commercial rollout in U.S. began mid-2025; ~150 systems installed worldwide by Q1 2026 (robotomated.com).
• Overview: Dedicated platform for peripheral lung nodule biopsy and diagnostic bronchoscopy.
• Clinical reach: Single-use steerable catheter system for >30 pulmonary procedures.
• Key features:
– Ultra-thin, robotically steerable catheter tip with integrated optics and ultrasound.
– Electromagnetic navigation with real-time 3D mapping.
– Medical image-guided AI targeting for sub-centimeter nodules.
• Economics: System $500–800 K; disposable catheter/probe $3 000.
• Adoption: >200 U.S. sites; shown to improve diagnostic yield by 25 % vs. manual techniques (robotomated.com).
• Overview: U.K.-based challenger focusing on minimal-access surgery and portability.
• Clinical reach: 25 + laparoscopic procedures (general surgery, gynecology, urology).
• Key features:
– Four independent, compact bedside units that mimic human arm articulation.
– Open console design for direct OR team communication.
– Plug-and-play instrument arms, ≤5 minutes setup time.
• Economics: System $1.0 M; instruments $1 200–1 800/case.
• Adoption: ~400 systems in Europe and Asia; U.S. FDA clearance expected late 2026 (en.wikipedia.org).
• Overview: Dual-application platform for neurosurgical and orthopedic procedures.
• Clinical reach: Cranial, spinal, knee, shoulder applications.
• Key features:
– Intraoperative stereotactic navigation with ≤1 mm targeting accuracy (neurosurgery).
– CT- or MRI-guided robotic drill and biopsy arm.
– Robotic-assisted alignment guide for unicompartmental knee arthroplasty.
• Economics: System $1.2–1.8 M; disposables vary $1 000–2 500.
• Adoption: >200 neurosurgery installations, ~100 orthopedic (robotomated.com).
• Overview: Focus on cost-effective digital laparoscopy via 5 mm reusable instruments.
• Clinical reach: General surgery, gynecology, colorectal.
• Key features:
– True haptic force feedback in scaled motion (3:1–6:1).
– Eye-tracking camera control and automated instrument repositioning.
– Fully reusable instruments reduce per-case disposables to <$200.
• Economics: System $0.7–1 M; minimal per-case costs.
• Adoption: ~250 hospitals globally; rapidly growing in community settings (robotomated.com).
• Overview: FDA-cleared “surgical humanoid” for precision spine instrumentation.
• Clinical reach: Lumbar and cervical pedicle screw placement.
• Key features:
– Bimanual humanoid arms with six wristed joints.
– NVIDIA Physical AI-driven real-time soft-tissue deformation modeling.
– Automated screw-trajectory planning with surgeon oversight.
• Economics: Launch price ~$1.8 M; single-use drill guides $400/case.
• Adoption: Limited early adopters at major U.S. spine centers as of Q1 2026 (reddit.com).
When evaluating surgical-robot investments, hospitals should weigh:
By matching platform strengths to institutional case mix, volume, and budget, surgical teams can maximize clinical outcomes while controlling long-term costs.
claude-sonnet-4-6
Here is a comprehensive overview of the best surgical robots in 2025–2026:
Intuitive Surgical remains the most dominant surgical robotics company in the world. With over 8,000 da Vinci units installed globally and more than 12 million procedures performed, it has set the benchmark for robotic-assisted surgery.
The da Vinci product family includes multiple models:
The system applies to a wide array of operations, including minimally invasive cardiac, colorectal, gynecology, head and neck, thoracic, urology, and general surgeries.
Intuitive Surgical also has an AI tool for the da Vinci 5 called Case Insights that can analyze surgical procedures and provide surgeons with post-surgical feedback on the part of the procedure that takes the longest and the areas where movements aren't as smooth or fluid.
Mako is designed specifically for orthopedic surgery, unlike general surgical robots such as da Vinci. Surgeons can plan the operation, make adjustments during the procedure, and use the robotic arm to make cuts with sub-millimeter accuracy. Hospitals and same-day surgery centers trust it for its precision, consistent outcomes, and faster recovery times.
The pre-operative planning process allows for accurate implant positioning, using data from a CT scan to generate a 3D model of the patient's bone structure, yielding a plan unique to the individual patient that the physician can review before operation.
Stryker has enjoyed a great deal of success in orthopedic surgery with its Mako robots, and recently announced Mako 4, the next generation of its platform.
Medtronic entered surgical robotics with the Hugo™ RAS, a modular, mobile-cart system designed as a lower-cost alternative to fixed-tower platforms like da Vinci.
Hugo is a modular, multi-quadrant platform designed for various surgical procedures. It features wristed instruments, 3D visualization, and surgical video capture options in Touch Surgery Enterprise.
Medtronic's Hugo soft tissue system won FDA clearance for its first indication, setting the stage for a U.S. market share battle with robotics leader Intuitive Surgical.
Zimmer Biomet offers two primary surgical robotics systems: ROSA® Knee and ROSA® Spine. Both are developed to assist with orthopedic and neurosurgical procedures. Like Mako, these platforms enable robot-guided bone preparation using real-time feedback and pre-op imaging, but with a stronger emphasis on digital data integration.
The Symani Surgical System pushes the limits of soft-tissue open surgery, giving surgeons greater precision and control. It also gives surgeons the chance to restore the quality of life for more patients, including those with cancer-related lymphedema who need microvascular and lymphatic repair.
Cleveland Clinic, New York University, the University of Pennsylvania, and Cedars-Sinai Medical Center in Los Angeles are also using the system.
CMR Surgical has received 510(k) clearance for its Versius Plus robotic system to perform gallbladder removal procedures.
CMR has stated that its soft tissue platforms are the second most used systems in the world.
Kai uses wristed instruments — surgical tools mounted on robotic arms with flexible, jointed tips that mimic the movements of the human wrist for precise control in tight spaces. Operated from a console, these instruments allow surgeons to connect blood vessels as small as 300 microns wide. Its "seven degrees of freedom" let the tools move in seven independent ways, giving them nearly the same dexterity as a human hand and wrist.
-
Artificial intelligence (AI) is being integrated into robotic surgery devices to automate surgical tasks like suturing or tissue dissection. These systems aim to improve consistency and reduce surgeon workload.
-
A 2025 meta-study found that AI-assisted robotic surgery systems can potentially cut operative time by about 25% and reduce intraoperative complications by 30%.
-
The surgical robotics market is expanding beyond general surgery into specialized fields like orthopedics, neurosurgery, and endovascular interventions, driven by the demand for minimally invasive surgery (MIS), which reduces hospital stays and recovery times.
These surgical robots are revolutionizing modern medicine, offering patients smaller incisions, faster recovery times, and significantly improved outcomes. The field is rapidly evolving, with AI and next-generation platforms pushing precision far beyond what human hands alone can achieve.
gemini-2.5-flash
The field of surgical robotics is rapidly advancing, with several companies and systems leading the way in providing enhanced precision, minimally invasive techniques, and improved patient outcomes. While "best" can be subjective and depend on the specific surgical application, some systems consistently stand out for their capabilities and widespread adoption.
Here are some of the top surgical robots and companies:
1. Intuitive Surgical - da Vinci Surgical System
The da Vinci system is the most widely used robotic surgery platform globally, with over 8,000 units installed and more than 12 million procedures performed.
2. Medtronic - Hugo RAS System
The Hugo RAS (Robotic-Assisted Surgery) system is a strong contender, designed for multi-specialty use.
3. Stryker - Mako SmartRobotics™
Stryker is a leader in orthopedic surgery with its Mako platform.
4. CMR Surgical - Versius Surgical System
Versius is gaining traction as a portable and scalable robotic system.
5. Medical Microinstruments (MMI) - Symani Surgical System
The Symani system is the first robotic system specifically designed for microsurgery.
Other notable companies and systems include:
The choice of the "best" surgical robot often depends on the specific surgical needs, budget, and desired outcomes. However, the da Vinci system, with its latest da Vinci 5, continues to set a high benchmark in the field.
sonar
The best surgical robots depend on the procedure, but the most established and widely recognized platform is Intuitive’s da Vinci system, which is built on nearly three decades of clinical experience and is known for precision, vision, and control. For orthopedics, Stryker’s Mako is a leading option, while Medtronic and Johnson & Johnson are major players in the broader surgical robotics market.
A useful way to think about “best” is by clinical use case:
A few important caveats:
If you want, I can also give you a ranked list by specialty — for example best robots for urology, general surgery, orthopedics, or gynecology.
이 질문에 답할 때 AI 플랫폼이 인용하는 웹사이트 및 도메인입니다.
모든 플랫폼에 걸쳐 “best surgical robots”에 대한 출처로 17개의 고유 도메인이 인용되었습니다. Google AI Overview는 www.youtube.com(을)를 시작으로 10개의 출처를 참조했습니다. ChatGPT는 10개의 출처를 인용했으며, www.reddit.com(이)가 가장 자주 등장했습니다. 여러 AI 플랫폼에 걸쳐 신뢰할 수 있는 출처로 등장하는 브랜드는 AI 기반 검색에서 상당한 우위를 점합니다.
사람들이 AI 플랫폼에서 관련 질문을 얼마나 검색하고 있는지 나타냅니다.
“best surgical robots”에 대해 5개의 관련 검색어가 확인되었습니다. 가장 검색량이 높은 검색어는 "best surgical robots"이며, 월간 AI 검색량은 38회입니다. 모든 관련 검색어의 총 합산 AI 검색량은 40회입니다. 이러한 관련 검색어는 medical devices 분야에서 브랜드가 AI 생성 추천에 노출될 수 있는 추가적인 기회를 의미합니다.
본 화면은 정적 스냅샷입니다. 지속적인 AI 가시성 모니터링, 경쟁사 벤치마킹, 인용 발자국을 개선하는 출처 기반 GEO 콘텐츠는 VayoMed의 Done-for-You 성장 엔진에 포함되어 있습니다.